Massachusetts Financial Services’s Aquestive Therapeutics AQST Stock Holding History

Massachusetts Financial Services’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-54,495	Closed	-$283K	–	907
2021 Q1	$283K	Sell	54,495 -6,457	-11%	-$34.4K	﹤0.01%	900
2020 Q4	$326K	Sell	60,952 -614	-1%	-$3.68K	﹤0.01%	859
2020 Q3	$299K	Buy	+61,566	New	+$402K	﹤0.01%	848
2019 Q4	–	Sell	-293,625	Closed	-$934K	–	804
2019 Q3	$934K	Sell	293,625 -179,628	-38%	-$673K	﹤0.01%	773
2019 Q2	$1.99M	Sell	473,253 -370	-0.1%	-$1.89K	﹤0.01%	733
2019 Q1	$3.27M	Sell	473,623 -307	-0.1%	-$2.15K	﹤0.01%	676
2018 Q4	$2.99M	Buy	473,930 +170,984	+56%	+$2.16M	﹤0.01%	681
2018 Q3	$5.3M	Buy	+302,946	New	+$4.99M	﹤0.01%	673

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Latash Investments Anchorage, Alaska $136M AUM 9.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Massachusetts Financial Services's AQST Position: Q2 2021 in Review

Massachusetts Financial Services sold out of Aquestive Therapeutics (AQST) in Q2 2021, closing a stake of 54,495 shares — an estimated $283K sold.

Massachusetts Financial Services first reported a position in AQST in Q3 2018 and held it in 8 quarters. The position peaked at $5.3M in Q3 2018. 60 funds tracked by Wall St. Rank hold AQST as of Q2 2021.

Massachusetts Financial Services reported no remaining Aquestive Therapeutics position as of Q2 2021 after selling out during the quarter.
Massachusetts Financial Services sold 54,495 Aquestive Therapeutics shares in Q2 2021, an estimated $283K.
Massachusetts Financial Services first reported a position in Aquestive Therapeutics in Q3 2018 and held it in 8 quarters.
Massachusetts Financial Services's Aquestive Therapeutics position peaked at $5.3M in Q3 2018.
60 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2021.

Based on Massachusetts Financial Services's 13F filing for Q2 2021, filed 13 Aug 2021.